Rxo (RXO) Gross Profit (2021 - 2026)

Rxo (RXO) has reported Gross Profit for 6 consecutive years, with $254.0 million the latest figure, recorded in Q1 2026.

• Gross Profit for Q1 2026 came in at $254.0 million, down 9.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 5.14% YoY), and the FY2025 annual result was $1.1 billion, up 14.82% from the prior year.
• Gross Profit was $254.0 million for Q1 2026 at Rxo, down from $266.0 million in the prior quarter.
• Over five years, Gross Profit peaked at $322.0 million in Q2 2022 and troughed at $214.0 million in Q1 2024.
• Average Gross Profit over 5 years is $264.8 million, with a median of $266.0 million recorded in 2025.
• Year-over-year, Gross Profit fell 25.47% in 2023 and jumped 31.91% in 2024.
• Over 5 years, Gross Profit stood at $278.0 million in 2022, then fell by 15.47% to $235.0 million in 2023, then soared by 31.91% to $310.0 million in 2024, then declined by 14.19% to $266.0 million in 2025, then retreated by 4.51% to $254.0 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $254.0 million in Q1 2026, $266.0 million in Q4 2025, and $284.0 million in Q3 2025.